Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaboxadol Open-Label Extension in Primary Insomnia
NCT00209950Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gaboxadol in Insomnia, sponsored by Lundbeck. Started Jul 2004; status: completed.
02
Drugs
gaboxadol
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00209950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209950.